Drugmakers use the media to tout coronavirus treatments that are still under review

“You had this data moving widely around NIH and the remdesivir leak was also in our minds,” the Moderna spokesperson said. But Peter Bach, director of Memorial Sloan-Kettering’s Center for Health Policy and Outcomes, said Moderna’s effort to preview its findings in the press “could be construed as an effort to make sure they are […]

from Newslanes https://ift.tt/2XDjLCH